AllerVie Health Announces the Creation of Advisory Council and Addition to Board of Directors

Originally Published on BusinessWire

DALLAS, TEXAS – January 15, 2024 – AllerVie Health, a leading provider of allergy and immunology services across the United States, is excited to announce two major initiatives designed to elevate patient care and strengthen the organization’s clinical leadership.

Introducing the AllerVie Advisory Council

In a significant step forward, AllerVie has formed the AllerVie Advisory Council (AAC), a clinician-led body that will provide invaluable insights into clinical practices, protocols, and operational projects. The council is designed to facilitate accelerated decision-making, ensuring that AllerVie continues to provide high-quality, patient-centered care as it expands across the nation.

“We believe that the AllerVie Advisory Council is a critical step forward for our company,” said Tae Kim, CEO of AllerVie Health and Chair of the Advisory Council. “This council brings together a talented group of clinical leaders whose combined experience and expertise will help us better serve our patients and strengthen our internal culture.”

The Role of the Advisory Council

The AAC will focus on key objectives, including:

• Advising and Endorsing: Providing feedback on clinical programs and initiatives to ensure they align with both provider perspectives and patient needs.
• Developing Best Practices: Helping formalize operational best practices in areas such as patient experience, diagnostics, treatment, compliance, and billing.

AllerVie Health is proud to announce the following distinguished members of the Advisory Council:

Provider Members:

• Dr. Weily Soong | Birmingham, Alabama
• Dr. Paul Keiser | Virginia and Pennsylvania
• Dr. Ashish Mathur | Cincinnati, Ohio
• Dr. Reena Patel | Hoover, Alabama
• Dr. Julia Sohn | Washington, D.C. and Germantown, Maryland
• Dr. Maxcie Sikora | Destin and Panama City, Florida
• Heather Morris, APRN, NP-C | Lubbock, Texas

Corporate Members:

• Tae Kim, CEO and Chair
• Rachel Russell, Chief Experience Officer
• Jessica Vogt, Chief Financial Officer
• Ross Boatwright, Vice President of Strategy and Integrations
• James Calderwood, Vice President of Operations
• Taylor Knutson, Council Secretary

Welcoming Dr. Ruchi Gupta to the Board of Directors

In addition to the creation of the Advisory Council, AllerVie is proud to announce the addition of Dr. Ruchi Gupta to its Board of Directors. Dr. Gupta is a renowned expert in food allergy and asthma research and is the founding director of the Center for Food Allergy & Asthma Research (CFAAR) at Northwestern University Feinberg School of Medicine.

With over 20 years of experience in the field, Dr. Gupta’s groundbreaking research in allergy and asthma epidemiology, as well as her expertise in pediatric care, will bring a new level of insight and innovation to AllerVie’s leadership. Her wealth of knowledge will be instrumental as the company continues its mission to expand access to allergy and immunology care.

Looking Ahead: One Mission, One Purpose, One Team

AllerVie Health’s vision is clear: One AllerVie. One Team. One Purpose. By uniting the collective expertise of clinical leaders like Dr. Gupta with strategic operational guidance from the AllerVie Advisory Council, the company is poised for continued growth and success. AllerVie remains committed to making a difference in the lives of its patients and advancing the field of allergy and immunology care.

To learn more about AllerVie Health, visit www.allervie.com.